|
CGGBP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.87827531306084E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.39490008222288E-10 |
| Normal-vs-Stage2 |
6.27239999939633E-08 |
| Normal-vs-Stage3 |
4.28324042900385E-13 |
| Normal-vs-Stage4 |
1.96179739120339E-11 |
| Stage1-vs-Stage2 |
4.168600E-01 |
| Stage1-vs-Stage3 |
7.762200E-03 |
| Stage1-vs-Stage4 |
1.253630E-02 |
| Stage2-vs-Stage3 |
2.775000E-01 |
| Stage2-vs-Stage4 |
2.628400E-01 |
| Stage3-vs-Stage4 |
9.229800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.41042774418565E-13 |
| Normal-vs-AfricanAmerican |
3.163500E-04 |
| Normal-vs-Asian |
1.01599999968727E-07 |
| Caucasian-vs-AfricanAmerican |
3.740600E-01 |
| Caucasian-vs-Asian |
5.883800E-01 |
| AfricanAmerican-vs-Asian |
6.447200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.75848224870379E-12 |
| Normal-vs-Female |
9.68414237689785E-12 |
| Male-vs-Female |
3.842600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.22829999504859E-08 |
| Normal-vs-Age(41-60Yrs) |
9.3869356732057E-12 |
| Normal-vs-Age(61-80Yrs) |
2.25464091840877E-12 |
| Normal-vs-Age(81-100Yrs) |
8.205900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.124030E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.901560E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.596400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.132600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.142400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.848200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.099800E-03 |
| Classical-VS-Follicular |
1.300350E-01 |
| Classical-VS-Other |
6.753600E-01 |
| Classical-VS-Normal |
1.43290046494826E-10 |
| Tall-VS-Follicular |
1.222220E-01 |
| Tall-VS-Other |
3.698800E-01 |
| Tall-VS-Normal |
1.6726999785277E-09 |
| Follicular-VS-Other |
9.337200E-01 |
| Follicular-VS-Normal |
4.77859996017571E-09 |
| Other-VS-Normal |
8.639200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.8620001054428E-12 |
| Normal-vs-N1 |
2.37050046258958E-10 |
| N0-vs-N1 |
3.925800E-01 |
|
|
